Amiglumide

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAmiglumide
Drug Alias NameCR-1795
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin A receptor antagonists
TargetsCholecystokinin A receptor
Therapy Area/IndicationsPancreatitisGastrointestinal DiseasesBiliary Dyskinesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRottapharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRottapharm
Active IndicationsN/A
Inactive IndicationsPancreatitisGastrointestinal DiseasesBiliary Dyskinesia

Other Information

ATC CodeN/A
Related LinksN/A